BioWorld MedTech

Aug. 11, 2011

Med-tech faces uncertainty in healthcare landscape

ATLANTA — If there was one word that could properly describe the feelings of medical device makers across the U.S., that word would be uncertainty. (Medical Device Daily) Read More

Washington roundup: CMS eyes wider indication for extracorporeal photopheresis

International report: First Latin American use of Medtronic Symplicity performed

New ventures: Misonix now enters surgical wound debridement market

Deals roundup: Despite buyout rejection, Alere acquires more Axis-Shield stock

Financings roundup: Masimo's board authorizes repurchase of up to 3M shares

Agreements/contracts: TrovaGene stops Sequenom, regains transrenal tech rights

Grants roundup: ApoCell awarded $2.9M contract for 12 alpha prototype units

HIT roundup: Boston Sci launches NLI for spinal cord stimulation

Med-Tech Notes

People in the News

Product Briefs

Abbott Vascular gets FDA approval for RX Herculink

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for May 21, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...